Publications

  • Publication Reference Year Symeres Authors Customer
    Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ-1 Subunit of Voltage-Gated Calcium Channel and the μ-Opioid Receptor ChemMedChem 2024, e202300473 2024 Anita Wegert, Wouter de Graaf, Frank van Holst, Giovanni Bolcato WeLab Barcelona

    Read more

  • Publication Reference Year Symeres Authors Customer
    High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of Plasmodium falciparum ACS Infect. Dis. 2024, XXXX, XXX, XXX-XXX 2024 Melloney Dröge, Bernard van Vliet, Jack den Hartog

    Read more

  • Publication Reference Year Symeres Authors Customer
    Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen J. Med. Chem. 2024 (67), 3039-3065 2024 Koen Hekking, Marjon Bolster, Sergio Maroto, Kees van Kekem, Frank Haasjes, Jack Slootweg, Patrick Oude Alink, Ron Dirks, Brian Kuijpers, Robin Doodeman, Dennis Smith

    Read more

  • Publication Reference Year Symeres Authors Customer
    Specific N-terminal attachment of TMTHSI linkers to native peptides and proteins for strain-promoted azide alkyne cycloaddition Chem. Commun., 2023, Advance Article 2023 Niels Hauwert Cristal Therapeutics

    Read more

  • Publication Reference Year Symeres Authors Customer
    Contemporary Chiral Resolutions Chim. Oggi., 2023, 41 (2) 2023 Michel Leeman

    Read more

  • Publication Reference Year Symeres Authors Customer
    Comparative biochemical kinase activity analysis identifies rivoceranibas a highly selective VEGFR2 inhibitor (Oncolines) Cancer Chemother Pharmacol., 2023 (6), 491-499 2023 Jeffrey Kooijman, Janneke Melis, Guido Zaman Elvar Therapeutics

    Read more

  • Publication Reference Year Symeres Authors Customer
    DT-0111: a novel P2X3 receptor antagonist (Organix) Purinergic Signalling, 2023 2023 Anu Mahadevan Danmir Therapeutics LLC

    Read more

  • Publication Reference Year Symeres Authors Customer
    The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation ChemMedChem 2023, e202300002 2023 Russell Craft EFMC

    Read more

  • Publication Reference Year Symeres Authors Customer
    European Medicinal Chemistry Leaders in Industry (EMCL) – On the Status and Future of Medicinal Chemistry Research in Europe ChemMedChem 2023, e202300127 2023 Luc van Hijfte

    Read more

  • Publication Reference Year Symeres Authors Customer
    Feasibility Study to Assess Canagliflozin Distribution and Sodium-Glucose Co-Transporter 2 Occupancy Using [18 F]Canagliflozin in Patients with Type 2 Diabetes Clin. Pharmacol. Ther. 2023 Mar 10 2023 UMCG Ton Visser, Andre Heeres UMCG

    Read more

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us